PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −4 vs. Q4 2021
- Shares held
- 55.2M
- +7.88M (+16.6%) vs. Q4 2021
- Total value
- $1.15B
- +$55.7M (+5.1%) vs. Q4 2021
- New holders
- 15
- 34 more added
- Sold out
- 19
- 30 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −91,464−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −68,845−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −66,743−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −39,777−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −33,568−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −23,971−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,168−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,593−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,264−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −8,942−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −3,841−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,785−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −182−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | – | – | – | – | Not filed |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |